Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 AMRI Appoints India Ops Leader | Contract Pharma

What are you searching for?

Sign in
Breaking News

AMRI Appoints India Ops Leader

Maddala to lead API manufacturing operations

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Subramanyam Maddala has been appointed president of India operations at AMRI. Mr. Maddala assumes leadership for the company’s Indian API manufacturing operations as well as responsibility for AMRI facility operations in Hyderabad and Aurangabad, India. He reports to Dr. Steven Hagen, AMRI’s vice president of pharmaceutical development and manufacturing.

Mr. Maddala has more than 20 years of operations, business development, and senior leadership experience in the manufacturing of APIs and intermediates, custom synthesis, and formulations in branded and generics markets. Most recently, he served as vice president, Contract Research and Manufacturing Services (CRAMS) and New Generics for Shasun Pharmaceuticals Ltd., and was responsible for its contract research and manufacturing business, including all vertical CRAMs businesses and new API generic efforts. Prior to that, Mr. Maddala held several roles of increasing responsibility at firms including Piramal India Ltd., Glenmark Pharmaceuticals, Medicorp/Matrix Labs, Torrent Pharmaceuticals, SOL and Lupin Laboratories.

“We are pleased to welcome Mr. Maddala to the AMRI leadership team and believe he is the right person to take AMRI’s chemical manufacturing business in India to the next level, including the capability to eventually manufacture multiple products in India to U.S. FDA standards,” said Dr. Hagen.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics